Neuroleptic malignant syndrome: an easily overlooked neurologic emergency
Ramadhan Oruch,1 Ian F Pryme,2 Bernt A Engelsen,3 Anders Lund4 1Department of Pharmacology and Toxicology, School of Pharmacy, Benghazi University, Benghazi, Libya; 2Department of Biomedicine, 3Department of Clinical Medicine, Section of Neurology, 4Department of Clinical Medicine, Section of Psych...
Guardado en:
Autores principales: | Oruch R, Pryme IF, Engelsen BA, Lund A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c431170cea9b4762b3ce7699f12cc8d5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome
por: Miguel Santos, et al.
Publicado: (2021) -
Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia
por: Cheng MF, et al.
Publicado: (2016) -
Síndrome neuroléptico maligno y poliserositis en paciente usuaria de clozapina: una asociación infrecuente
por: Eymin L,Gonzalo, et al.
Publicado: (2005) -
Anti-N-methyl-D-aspartate receptor encephalitis mimics neuroleptic malignant syndrome: case report and literature review
por: Wang HY, et al.
Publicado: (2019) -
Paroxysmal hyperthermia, dysautonomia and rhabdomyolysis in a patient with Lesch–Nyhan syndrome
por: Mandeep Rana, et al.
Publicado: (2021)